The global biopharmaceutical industry has witnessed steady growth over the years due to a surge in the sales of vaccines, statins, and therapeutics. This has, in turn, created a need for purification, thus increasing the demand for prepacked chromatography columns.
Prepacked chromatography columns have also been integrated in the biopharmaceutical industry and its acceptance is growing at a rapid pace. Government organizations in countries such as Canada, the U.S., and Germany have been upping their investments, grants, and funds in order to develop as well as bring innovative products to the market. This has also supported the prepacked chromatography columns market.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6014
The global market is anticipated to expand at a CAGR of 8.4% during the forecast period, rising from a value of US$1.6 bn in 2015 to US$3.3 bn by 2024.
Protein Purification Segment to Witness Highest Growth Rate
On the basis of application, the highest growth rate is witnessed by the protein purification segment whereas sample preparation segment has been leading in the market. On the basis of product type, the global prepaid chromatographic columns market is led by >1L segment. This segment is also expected to expand at the fastest pace as compared to any other segments during the forecast period.
Versatility of Prepacked Chromatography Columns to Generate High Demand from Across Industries
According to TMR, “one of the key factors boosting the growth of the global pre-packed chromatographic columns market is its versatility and suitability across industries in order to detect and separate organic molecules and components.” A significant role is played by pre-packed chromatographic columns in the production of biopharmaceutical products, research, chemicals, forensics, food and beverage, biotechnology, and agriculture. As the application area of these columns is extremely wide, the global pre-packed chromatographic columns market is expected to continue to grow.
High Price May Restrict Market’s Growth
In addition to this the increasing number of monoclonal antibodies which are being used for clinical trials driving the growth to market. The number of monoclonal antibodies which have been approved for therapeutic applications is also increasing and this is favouring the global pre-packed chromatographic columns market. On the other hand, the high price of pre-packed chromatographic columns may act as the restraining factor which will slow down the growth of this market. Also, there are limitations as a result of plugging and fouling which will also impact the market negatively.